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Abstract
Background: Careful selection of patients with colorectal liver metastases for liver resection should minimize the risk of
unnecessary laparotomy due to unresectable disease. The impact of staging laparoscopy with laparoscopic ultrasonography
(LapUS) on clinical decision making in selected patients with potentially resectable colorectal liver metastases was
evaluated. Patients and methods: Staging laparoscopy with or without LapUS was performed in 77 of 415 consecutive
patients (19%) with colorectal liver metastases deemed potentially resectable following liver-specific CT and/or MRI
scanning. Retrospective analysis of prospectively collected data compared clinical outcomes with those in whom laparoscopy
had been deferred in favour of laparotomy. Results: Staging laparoscopy was successful in 76 of 77 patients (99%). Adverse
events occurred in three patients (4%): bowel injury n/2; late port site metastasis, n/1. Laparoscopic staging identified
factors precluding curative resection in 16 patients (21%), thus averting unnecessary laparotomy. Of the 57 patients (74%)
staged laparoscopically who underwent surgical exploration, 7 patients (12%) were unresectable and liver resection was
achieved in 50 (88%). Discussion: Laparoscopic staging remains useful in detecting occult intra- and extra-hepatic tumour
in selected patients with potentially operable colorectal liver metastases.
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Introduction
Hepatic resection offers the best chance of cure for
patients with colorectal liver metastases [1,2]. As less
than one-quarter of all patients presenting with color-
ectal liver metastases are suitable for liver resection
with curative intent, the successful identification of
those with resectable disease for operative interven-
tion remains a fundamental goal. Conversely, under-
staging of the tumour may result in the abandonment
of the operation to the detriment of the patient.
Despite advances in cross-sectional imaging techni-
ques during the last decade, there has been concern
regarding the incidence of non-therapeutic laparot-
omy [3], and this has stimulated interest in the role of
staging laparoscopy (with or without laparoscopic
ultrasonography, LapUS) in an attempt to detect
previously unsuspected intra- or extra-hepatic disease
[411].
However, the need to perform routine staging
laparoscopy in all patients with potentially operable
colorectal liver metastases has been questioned in
favour of a more selective approach [8,9,11]. In this
way, the reservation of laparoscopy for selected high-
risk patients may increase the diagnostic yield and
justify the inconvenience, cost and potential morbidity
inherent in the technique.
This study evaluated the impact of selective staging
laparoscopy (with LapUS) on the management of
patients with colorectal liver metastases in the context
of a specialist hepatobiliary unit with a high volume
liver resection practice.
Patients and methods
The study comprised 415 consecutive patients with
colorectal liver metastases referred during a 4-year
period (1 January 2000 to 31 December 2003).
Patients were identified from a prospectively main-
tained computer database comprising 147 data fields.
In all, 77 of 415 patients underwent staging
laparoscopy (19%) and their case notes were reviewed
retrospectively for further information regarding op-
eration details and clinical decision making (‘laparo-
scopy group’). All had been considered potential
candidates for hepatic resection with curative intent
on the basis of preoperative cross-sectional imaging.
Criteria for operability required the potential for
complete resection of all liver metastases, regardless of
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size, number, distribution or width of resection
margin. In addition, a sufficient volume of viable liver
parenchyma (at least 25% of normal parenchymal
volume as estimated from CT and/or MRI) must be
preserved. Patients who had favourable preliminary
abdominal CT and/or MRI scans, usually performed
at the referring institution, were considered for liver
resection. Repeat staging investigations at North
Hampshire Hospital were performed following refer-
ral and comprised both CT arterioportography
(CTAP) and MRI in 5 patients, CTAP alone in 28
patients and MRI only in 44 patients. Patient selec-
tion for liver resection was based on these secondary
imaging investigations.
The technique of CTAP has been described pre-
viously in detail [12]. During the latter part of the
study from October 2001 onwards, all patients were
assessed by MRI scanning according to a standardized
protocol using a 1.5 T Siemens Symphony magnet
with phased array body coil (Siemens AG, Munich,
Germany). All scans were performed during sus-
pended respiration in the axial plane. The following
sequences were used: T1 weighted in and opposed
phase chemical shift imaging (8 mm slice thickness),
T2 HASTE (6 mm slice thickness) and TRUE FISP
(10 mm slice thickness). An axial fat saturated T1
weighted volume acquisition (VIBE) (2 mm slice
thickness) was acquired prior to intravenous contrast
administration. The choice of contrast agent varied
but routinely included gadolinium (OmniscanTM;
gadodiamide, Amersham Health AS, Oslo, Norway)
and/or a liver-specific agent (usually Resovist†;
Schering AG, Baar, Switzerland). Scans were ac-
quired in the arterial, portal venous and equilibrium
phases using the VIBE sequence following the admin-
istration of intravenous contrast. All post-contrast
volume acquisitions were reviewed on a 3D work
station.
Patients referred with colorectal liver metastases
and an unfavourable or indeterminate pattern of
disease were subjected to a ‘test of time’ for 36
months. During this time further sequential imaging
investigations were performed.
Patients were selected for laparoscopic staging
according to the presence of one or more of the
following criteria:
. Unfavourable primary tumour status where there
were concerns regarding the risk of locoregional
recurrence. Specifically, these included those
patients with pT4 stage or circumferential resec-
tion margin involvement on histopathology, and/
or perforation and/or acute obstruction at the
index operation.
. Multiple bilobar metastases where there was
concern regarding the feasibility or safety of liver
resection and where radiological imaging had
been regarded as indeterminate.
. Hepatic parenchymal assessment where there
was concern regarding the magnitude of the
planned liver resection and, specifically, the
quantity and/or quality of the liver remnant.
. In addition to the above, where there were
concerns regarding medical co-morbidity and
the fitness of the patient for major resectional
surgery under prolonged general anaesthesia,
laparoscopic staging also served as a ‘test of
anaesthesia’.
Staging laparoscopy with LapUS was performed as
a separate procedure from the planned liver resection
under general anaesthesia with full muscle relaxation.
All laparoscopic procedures were performed or su-
pervised by a single operator (T.G.J.) using a sys-
tematic approach, which has been described in detail
elsewhere [4]. Careful inspection of the abdominal
cavity was performed with a 3CCD camera (Olympus
OTV SX2, Keymed Ltd, Southend on Sea, UK) and
10 mm diameter 308 telescope. Usually a second 10
mm or 5 mm diameter port was inserted, to inspect
the initial entry site for proximity to adherent bowel,
to retract viscera and elevate the left side of the liver,
to perform biopsy of suspicious peritoneal or liver
nodules and to facilitate LapUS.
The technique of LapUS has also been described in
detail [4]. A 10 mm diameter 7.5 MHz linear array
laparoscopic transducer with a 4 cm ‘footprint’ was
used and real-time scanning was observed on the
adjacent scanner (Aloka SSD 900, KeyMed Ltd). A
systematic sonographic examination of the entire liver
was performed, with particular attention to the porta
hepatis and para-coeliac regions for suspicious nodes.
Laparoscopic examination was considered limited if
adhesions precluded a good view of the liver and site
of previous colorectal resection. The procedure was
considered as having failed if no relevant areas could
be inspected satisfactorily. Extensive adhesiolysis was
generally avoided in staging laparoscopy. Open surgi-
cal exploration was deferred in those patients in whom
factors precluding curative resection were identified
on laparoscopic assessment.
An attempt at open liver resection without prior
laparoscopic staging (‘laparotomy group’) was made
in 338 of 415 (81%) patients who had been deemed
potentially resectable following radiological imaging.
Liver resections were regarded as potentially curative
when the surgeon undertook removal of all macro-
scopic disease. Histological demonstration of tumour
capsular breach during parenchymal transection was
regarded as curative on an intention to treat basis.
Radical en-bloc resection of locally invaded dia-
phragm, omentum, small bowel and stomach were
included in this category of potentially curative
surgery. However, patients with diffuse peritoneal or
omental carcinomatosis, or extrahepatic tumour in-
volving coeliac nodes, were typically regarded as
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inoperable and their operations were concluded
following appropriate biopsies.
Laparotomy was usually performed via an upper
midline incision with right subcostal extension. Fol-
lowing careful adhesiolysis and mobilization of the
liver, inspection, palpation and intraoperative ultra-
sound examination of the liver and extrahepatic
tissues were performed and a final decision was
made regarding resectability. Details regarding the
technique of liver resection, typically using the tech-
niques of low central venous pressure anaesthesia and
‘bloodless’ dissection using the cavitron ultrasonic
surgical aspirator (CUSA Ex, Valleylab Inc., Amer-
sham, Bucks, UK) and argon beam coagulation, have
been described previously [13].
The principal study outcome measure was the
decision to proceed with liver resection with curative
intent, or its abandonment, following laparoscopic
staging (laparoscopy group, n/77) or surgical ex-
ploration (laparotomy group, n/338). The outcomes
were analysed and compared. Patients undergoing
laparoscopic liver resection or redo liver resection for
colorectal metastases were not included in the study.
Neither radiofrequency ablation nor hepatic artery
infusion techniques were employed in patients found
to be unresectable at laparoscopy or laparotomy in
this study.
Results
In all, 77 of 415 patients comprised the laparoscopy
group (19%), in whom some 112 previous laparo-
tomies had been performed. Twelve patients had
stomas (16%). Satisfactory access to the peritoneal
cavity was achieved in 76 of 77 patients (99%) and, in
3 patients (4%), access to the peritoneal cavity
required attempts at cut-down at more than one
site. Only limited laparoscopic examinations were
achieved due to adhesions in 10 patients (13%).
Serious adverse events were recorded in three
patients (4%), two of which involved the laceration
of small bowel loops adherent to the anterior abdom-
inal wall. In each instance the small bowel injury was
identified immediately and repaired by primary su-
ture. Postoperative recovery was uncomplicated and
both patients were discharged home within 2 days.
Both patients did undergo liver resection. One pa-
tient, in whom no tumour dissemination had been
discovered at laparoscopy, presented with a late
laparoscopic port site metastasis 5 months after
abandonment of attempted liver resection because of
intrahepatic tumour encroachment upon the hepatic
venous confluence.
The impact of laparoscopic staging on clinical
management decisions, and the outcomes in patients
in whom liver resection was attempted, are shown in
Figure 1. Sixteen of 77 (21%) patients in the
laparoscopy group were found to have factors pre-
cluding liver resection with curative intent because of
peritoneal carcinomatosis (n/7), multiple/bilobar
metastases (n/5), malignant regional lymphadeno-
pathy (n/4) and/or insufficient residual liver volume
(n/3). LapUS alone was responsible for upstaging
four patients (5%) in whom laparoscopic inspection
had demonstrated no adverse findings (malignant
regional lymphadenopathy and/or bilobar metas-
tases).
Forty-one of 415 patients (10%) had previously
been subjected to biopsy of their potentially resectable
liver lesions, 9 (22%) of whom underwent laparo-
scopic staging. Of these nine patients, one had
histologically proven malignant body wall seeding
which was excised at the time of liver resection
following negative laparoscopic biopsy of a suspicious
peritoneal nodule. The other 32 biopsied patients
proceeded directly to laparotomy, 5 of whom were not
resected because of peritoneal carcinomatosis, while
the other 27 patients underwent curative liver resec-
tion.
Four patients in whom no absolute contraindica-
tions to liver resection were discovered at laparoscopy
subsequently failed to proceed to operation. One of
these patients declined the offer of definitive surgery.
Evidence for extrahepatic tumour was defined follow-
ing concurrent imaging in three of these patients.
Fifty-seven patients in the laparoscopy group pro-
ceeded to surgical exploration, in 50 (88%) of whom
hepatic resection on an intention to treat basis was
achieved successfully. Findings contraindicating liver
resection were encountered in the remaining seven
patients (12%) who had been staged laparoscopically
and whose operations were subsequently abandoned.
Reasons for laparoscopic failure included occult
extrahepatic disease comprising regional lymphade-
nopathy (n/4), and the discovery of more extensive
intrahepatic tumour where it was not thought possible
to achieve a radical margin of resection because of
tumour invasion of the hepatic venous confluence
and/or inferior vena cava (n/3). However, as pre-
viously described, one patient in whom laparoscopy
had been limited by adhesions, and in whom a heavy
burden of post-chemotherapy necrotic lymph nodes
was the reason for abandoning subsequent attempts at
liver resection, underwent curative hepatic resection
5 months later following a favourable ‘test of time’.
More extensive intrahepatic disease than had been
identified laparoscopically was encountered at opera-
tion in another patient and an extended right hepa-
tectomy plus local resection of an unexpected segment
3 metastasis was performed. Although a non-radical
resection margin was obtained, this patient was not
regarded as having had a false negative laparoscopy
because of the clinical decision to proceed with liver
resection with curative intent on an intention to treat
basis.
In the laparotomy group, 311 of 338 patients (92%)
achieved liver resection, while operation was aban-
doned in 27 patients (8%) due to the discovery of
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unexpected intrahepatic disease (n/14), extrahepatic
disease (n/14) or both intrahepatic and extrahepatic
disease (n/1).
Discussion
Laparoscopic staging performed in the aftermath of
major bowel resection, stoma formation and/or sys-
temic chemotherapy can be technically challenging
and is associated with a small but definite risk of
serious complications. Our experience confirms that
safe laparoscopic access is almost always feasible. In
this regard our results compare favourably with those
of others [10,14], and highlight the necessity of early
recognition and repair of the occasional visceral injury.
The single instance of late laparoscopic port site
seeding in this series draws attention to a serious but
extremely rare complication in patients with colorectal
liver metastases. Despite this, support for a continuing
role for staging laparoscopy in selected patients with
colorectal liver metastases under consideration of
curative liver resection has been provided.
Although the impact of laparoscopic staging in
detecting ‘occult’ disease has been evaluated exten-
sively in the context of patients with a variety of
hepatobiliary, pancreatic and oesophagogastric malig-
nancies [7,15,16], there has been a relative paucity of
evidence regarding the precise contribution of laparo-
scopy to the evaluation of patients with potentially
resectable colorectal liver metastases.
Cross-sectional imaging based on CT and/or MRI
techniques has evolved significantly over the last
decade [17] and remains at the core of the staging
algorithm for such patients. However, these modal-
ities can be fallible in detecting low volume intrahe-
patic and extrahepatic disease in a proportion of
patients. While countless published series have testi-
fied to the effectiveness of liver resection in patients
with colorectal liver metastases, details quantifying
the number of patients understaged in this way and
subjected to unnecessary (non-curative) laparotomy
have tended to be elusive. In this regard, the
experience of Jarnagin and colleagues at Memorial
Sloan Kettering Cancer Center between 1992 and
1997 provided a reality check [3]. Of 416 consecutive
patients with colorectal liver metastases deemed
potentially operable, 79% were resected as planned,
while factors precluding resection (extrahepatic in
49%, intrahepatic in 51%) were encountered in 87
patients (21%).
The negative effects of such unnecessary operations
are self-evident, and include physical (postoperative
pain, immunosuppression, potential complications),
psychological (anxiety, false hope) and health eco-
nomic factors. Palliative surgical interventions such as
ablation techniques and regional hepatic artery im-
plantation therapy have not been proven to be
beneficial in this scenario and may not justify lapar-
otomy, while subsequent delays in commencing
palliative chemotherapy are inevitable [11].
In this study, 16 of 77 patients (21%) were spared
this fate as a direct consequence of laparoscopic
staging. This seems a reasonable yield in support of
both the technique and the selection policy practised
in this patient group. Comparison with previous
studies is complex as the results of others have varied
widely. Previous work performed during the 1990s
tended to report higher yields of 2736% following
laparoscopic staging as a prelude to liver resection
[47]. However, these series comprised patients with
a variety of liver tumours, not just those with color-
ectal liver metastases, and followed radiological stu-
dies which might be considered inferior by
contemporary standards. In patients specifically with
potentially resectable colorectal liver metastases,
modest laparoscopic yields of only 514% have
415 consecutive patients with potentially
resectable colorectal liver metastases
Laparotomy group





n = 27 (8%)
Liver resection
n = 311 (92%)
Laparoscopy group
n = 77 (19%)
Unresectable
n = 16 (21%)
Not operated (other)
n = 4 (5%)
Surgical
exploration
n = 57 (74%)
Liver resection
n = 50 (88%)
Unresectable
n = 7 (12%)
Figure 1. Outcome in 415 consecutive patients with colorectal liver metastases considered potentially suitable for liver resection.
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been reported in some more recent studies [8,10,11],
which are at variance with the higher incidences of
management-changing findings of 33% [9] and 67%
[14] described in other contemporary reports. Indeed,
Thaler and colleagues achieved liver resection in just
23 of 69 potentially operable patients (33%) as a
direct consequence of the findings of staging laparo-
scopy with ultrasound despite having been preceded
by routine spiral contrast CT scans and the liberal use
of PET-CT [14]. Intangibles which may have influ-
enced such disparity in outcomes include varying
quality of pre-laparoscopy investigations, the degree
of selectivity exercised in performing laparoscopic
staging and differences in the indications for and
practice of curative liver resection performed within
individual institutions.
The adoption of selective laparoscopic staging in ‘at
risk’ patients with colorectal liver metastases has
accompanied substantial improvements in modern
radiological imaging techniques and concerns regard-
ing diminishing diagnostic yields when laparoscopy is
performed routinely [8,10]. In recent years, the
concept of the clinical risk score (CRS) as a basis
for selective laparoscopic staging has been developed
and popularized by Jarnagin and co-workers [8]. The
CRS is calculated from up to five criteria, namely
lymph node positive primary tumour, disease-free
interval (B/12 months), number of hepatic tumours
(/1), serum carcinoembryonic antigen level (/200
ng/ml), and size of largest hepatic tumour (/5 cm
diameter). The overall yield of laparoscopic staging in
103 patients was 14%, rising from 4% in those with a
CRS/2 up to 27% in patients with a CRS/2 [8].
Further work from the same group has validated these
findings, citing the avoidance of unnecessary lapar-
otomy following laparoscopic staging in 24% of that
subgroup of patients with a CRS of 4 or 5 [11].
Similarly, Metcalfe and colleagues [9] selected 24 of
73 patients with potentially operable colorectal liver
metastases for staging laparoscopy on the basis of
shorter disease-free intervals and multiplicity of le-
sions, 8 of whom were found to be unresectable at
laparoscopy (33%).
While the specific criteria for selection adopted in
the present study differ from those underpinning the
CRS, the results generally concur with those of recent
studies seeking to assess the impact of selective staging
laparoscopy [8,9,11] and by and large based on a
similar concept. Furthermore, the relatively low
incidence of non-therapeutic laparotomy (8%) in the
laparotomy group in the present study reproduces the
findings of Metcalfe et al. (6% unresectable) [9], and
appears to endorse selective laparoscopic staging
based on these criteria.
The inclusion for laparoscopic staging of those
patients with potentially operable colorectal liver
metastases in whom injudicious attempts at biopsy
had been carried out was of particular interest. Such
patients may justifiably be considered at increased risk
of extrahepatic tumour dissemination and poorer
oncological outcome [18,19]. However, laparoscopy
had minimal impact in detecting post biopsy seeding
in those patients examined and does not seem to be
indicated for this reason alone.
The fallibility of laparoscopic staging itself is
reflected by the 7 patients out of 57 (12%) in whom
false negative laparoscopies resulted in unnecessary
laparotomy plus the one non-radical resection. This
affirms the experience of others where similar out-
comes followed 9% [10] and 17% [9] of laparoscopic
examinations. While views of peritoneal and omental
seeding may be obscured by adhesions in some cases,
it is usually undetected malignant regional lympha-
denopathy which accounts for failure during laparo-
scopy to detect extrahepatic disease [4,8,11,14]. The
use of LapUS-guided fine-needle aspiration (FNA) or
assessment of lymph nodes might be expected to
improve the detection rate, but this was not our
experience. Intrahepatic disease contraindicating at-
tempts at resection, particularly deep-seated tumour
involving the hepatocaval area, may not always be
apparent at laparoscopy (despite using LapUS) and
accounted for half of our laparoscopic ‘misses’.
In much the same way that intraoperative ultra-
sonography has become an indispensable and ubiqui-
tous technique among hepatobiliary surgeons [20], so
it has been suggested that LapUS may address the
lack of tactile feedback and enhance the yield of
laparoscopy in detecting such occult disease
[4,6,7,16]. However, details regarding the precise
contribution of LapUS over and above that of
laparoscopy in patients with colorectal liver metas-
tases have been vague. Our attempt to quantify its role
defined four patients (5%) who were upstaged by the
findings of LapUS alone, representing a small but
important contribution.
Malignant regional lymphadenopathy is a recog-
nized pitfall in the staging of patients with colorectal
liver metastases [8] and, despite the use of LapUS,
continued to confound efforts at preoperative detec-
tion in this series. Malignant hilar and para-coeliac
nodes may not necessarily be enlarged or exhibit
specific sonographic features, and their subtle mor-
phology can present a diagnostic challenge even
during laparotomy and trial dissection. Nevertheless,
in recent work reported by Thaler and colleagues,
nodal disease was successfully detected in 11 of 12
documented cases using staging laparoscopy with
LapUS, in patients in whom both CT and PET-CT
had been performed routinely [14]. They excised and
sent for immediate pathological sectioning all lymph
nodes that were round, heterogeneous or displacing
adjacent tissues.
The novel biological imaging technique of PET-CT
does, however, continue to attract interest as a non-
invasive means of improved staging in patients
with potentially operable colorectal liver metastases.
While initial enthusiasm for PET-CT may have been
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tempered by its limitations in evaluating intrahepatic
disease and its poor specificity, recent reports com-
paring PET-CT with good quality contrast-enhanced
CT in patients with metastatic colorectal cancer have
demonstrated its superior sensitivity in detecting
occult extrahepatic disease [21,22], locoregional re-
currence of primary colorectal malignancy and in-
trahepatic recurrence of metastases following liver
resection [22]. Further study is required to determine
whether laparoscopic staging becomes complemen-
tary to or supplanted by PET-CT in this role.
Overall, approximately one-fifth of all patients
presenting with potentially resectable colorectal liver
metastases were selected for laparoscopic staging
having had ‘state of the art’ cross-sectional imaging.
About a fifth of these patients were found to have
occult disease which averted unnecessary surgical
exploration. These findings support the role of
laparoscopy and LapUS in complementing the con-
ventional staging algorithm and as a problem-solving
modality in borderline cases of indeterminate resect-
ability.
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